Atrium Therapeutics, Inc. (RNA)
7.84
-0.30
(-3.69%)
USD |
NASDAQ |
Oct 02, 16:00
7.98
+0.14
(+1.79%)
After-Hours: 20:00
Atrium Therapeutics Market Cap : 134.11M for Oct. 2, 2026
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| October 02, 2026 | 134.11M |
| October 01, 2026 | 139.24M |
| September 30, 2026 | 141.64M |
| September 29, 2026 | 144.03M |
| September 28, 2026 | 144.03M |
| September 25, 2026 | 141.81M |
| September 24, 2026 | 140.10M |
| September 23, 2026 | 142.49M |
| September 22, 2026 | 157.72M |
| September 21, 2026 | 157.20M |
| September 18, 2026 | 153.10M |
| September 17, 2026 | 163.53M |
| September 16, 2026 | 162.51M |
| September 15, 2026 | 172.60M |
| September 14, 2026 | 174.65M |
| September 11, 2026 | 177.22M |
| September 10, 2026 | 177.05M |
| September 09, 2026 | 179.78M |
| September 08, 2026 | 194.15M |
| September 04, 2026 | 242.73M |
| September 03, 2026 | 249.75M |
| September 02, 2026 | 240.51M |
| September 01, 2026 | 235.55M |
| August 31, 2026 | 227.85M |
| August 28, 2026 | 233.33M |
| Date | Value |
|---|---|
| August 27, 2026 | 239.14M |
| August 26, 2026 | 236.92M |
| August 25, 2026 | 239.48M |
| August 24, 2026 | 232.98M |
| August 21, 2026 | 225.80M |
| August 20, 2026 | 230.59M |
| August 19, 2026 | 234.52M |
| August 18, 2026 | 219.64M |
| August 17, 2026 | 221.69M |
| August 14, 2026 | 219.64M |
| August 13, 2026 | 210.92M |
| August 12, 2026 | 208.18M |
| August 11, 2026 | 209.89M |
| August 10, 2026 | 209.37M |
| August 07, 2026 | 211.08M |
| August 06, 2026 | 207.15M |
| August 05, 2026 | 200.82M |
| August 04, 2026 | 197.40M |
| August 03, 2026 | 193.81M |
| July 31, 2026 | 194.15M |
| July 30, 2026 | 196.03M |
| July 29, 2026 | 191.24M |
| July 28, 2026 | 196.54M |
| July 27, 2026 | 197.91M |
| July 24, 2026 | 196.54M |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Tenax Therapeutics, Inc. | 63.26M |
| Exicure, Inc. | 7.33M |
| Century Therapeutics, Inc. | 276.24M |
| Absci Corp. | 1.899B |
| Celularity, Inc. | 46.69M |
Market Cap Related Metrics
| PS Ratio | 4.905 |
| PEG Ratio | -0.0054 |
| Price to Book Value | 0.625 |
| Price | 7.84 |
| Earnings Yield | -58.77% |
| PEGY Ratio | -0.0054 |